{"id":"W4367052531","doi":"10.1186/s13046-023-02668-3","title":"Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors","year":2023,"lang":"en","type":"erratum","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Refractory (planetary science); Monoclonal antibody; Medicine; Clinical trial; Cancer research; Oncology; Antibody; Internal medicine; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007172402,0.0004747826,0.001800752,0.0008910805,0.0002039452,0.00007748334,0.0009458466,0.001240882,0.0005409297],"category_scores_gemma":[0.002671665,0.0004150037,0.001097304,0.0007343309,0.000824891,0.00003230357,0.0004464517,0.003990223,0.0000184997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005968401,"about_ca_system_score_gemma":0.00345038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001291571,"about_ca_topic_score_gemma":0.00103472,"domain_scores_codex":[0.9905457,0.001575754,0.004225266,0.0009552805,0.001734071,0.0009639357],"domain_scores_gemma":[0.9959457,0.0006867257,0.001424733,0.0006130409,0.0007994006,0.0005304333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1005958,0.02090882,0.02390176,0.0001915389,0.0008526451,0.001505593,0.0003450942,0.0001807543,0.178446,0.000006588798,0.6643537,0.00871182],"study_design_scores_gemma":[0.2251176,0.1096047,0.01127249,0.003146479,0.0001024811,0.00009758674,0.002700081,0.00130965,0.08931145,0.0000479985,0.5557974,0.001492079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9753613,0.005481548,0.000004443374,0.0002617653,0.01630968,0.001235518,0.0001077782,0.000008411979,0.001229516],"genre_scores_gemma":[0.9464188,0.01942856,0.00005588887,0.0000472243,0.01187424,0.0001659693,0.0005894215,0.000149044,0.0212709],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1245219,"threshold_uncertainty_score":0.9998302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2061203125853942,"score_gpt":0.577063523192409,"score_spread":0.3709432106070147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}